Financial Health Assessment: TRISTAR TECH SOLUTIONS LIMITED

1. Financial Health Score: D+

Explanation: The patient is surviving but relies heavily on life support from creditors and its parent company. While the business has recently stabilized its top-line historical losses, it suffers from a chronic condition (deep accumulated deficits) and acute short-term breathing difficulties (negative working capital). The ongoing operational loss for 2024 indicates the business is still bleeding cash, making its financial wellness fragile.

2. Key Vital Signs

• Working Capital (Oxygen Supply): -£72,097 Current Assets (£180,269) are significantly lower than Current Liabilities (£252,366). In medical terms, the business is not taking in enough oxygen to sustain its daily respiratory needs. It cannot cover its short-term debts using its short-term assets, which is a classic symptom of financial distress.
• Current Ratio (Blood Pressure): 0.71 A healthy business typically has a current ratio of 1.5 to 2.0 (meaning £2 of assets for every £1 of short-term liabilities). Tristar has just £0.71 of assets for every £1 of liabilities due within a year. Its financial blood pressure is dangerously low.
• Cash Reserves (Pulse): £51,523 Cash levels have dropped by roughly 42% from the prior year (£88,639). A weakening pulse like this indicates the business is consuming its liquid energy reserves just to keep the lights on.
• Accumulated Losses (Chronic Condition): -£1,956,592 The Profit and Loss reserve is deeply negative. Over its lifetime, the company has distributed or lost nearly £2 million more than it has earned. While share capital (£1.9M) technically props up the net assets to a positive £81,607, the underlying tissue is heavily scarred by historical deficits.
• Operational Bleeding: -£15,746 By comparing the 2024 P&L reserve (-£1,956,592) to the 2023 reserve (-£1,940,846), we can see the company bled a further £15,746 during the 2024 financial year. The hemorrhage has slowed compared to previous years, but the patient is still losing blood.

3. Diagnosis

The financial data reveals a business suffering from Chronic Insolvency Symptoms with Acute Liquidity Deficiencies.

The most alarming symptom is the negative working capital. When a business owes more in the short term than it can readily convert to cash, it is technically insolvent on a day-to-day basis. The company is only surviving because its creditors—specifically "Other creditors" (£144,307)—are not demanding immediate payment.

The notes reveal that £24,206 of this is owed to Garden Star Establishment, the company's parent. This is the financial equivalent of being on a ventilator; the parent company is providing the life support needed to keep the patient breathing. If this related party were to call in its debt, Tristar Tech Solutions would likely face severe, potentially fatal, cash flow complications.

Furthermore, the company's asset base is heavily weighted toward intangible assets (£116,216) and investments (£51,929). Intangibles are notoriously difficult to monetize in a distress scenario. If the business suffered a sudden shock, its "bone marrow" (fixed assets) would not yield much cash to pay off creditors.

4. Recommendations

To stabilize the patient and improve long-term financial wellness, the following interventions are required:

1. Blood Transfusion (Capital Injection): The negative P&L reserve and negative working capital need to be addressed through a capital injection. The parent company (Garden Star Establishment) should consider converting the £24,206 it is owed into equity, which would reduce current liabilities and improve the current ratio.
2. Stem the Bleeding (Achieve Operational Profitability): The company must stop the ongoing operational losses. With 11 employees and an IT services business model, management needs to review margins and overheads to ensure that revenue generation exceeds the cost of delivery.
3. Improve the Respiratory Cycle (Working Capital Management): The business must accelerate the collection of its trade debtors (£74,812) and carefully manage its trade creditors (£76,825). Extending creditor payment terms (where possible) and shortening debtor days will help improve the cash conversion cycle, ensuring more oxygen flows through the business.
4. Review Intangible Health: With £116k tied up in intangible assets (likely capitalised development costs), management must ensure these assets are actually generating future economic benefits. If they are not, they should be written off to present a truer picture of financial health to stakeholders.